Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
Phase 2 Recruiting
30 enrolled
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Phase 2 Recruiting
53 enrolled
A Study in Adults With Untreated Acute Lymphoblastic Leukemia
Phase 2 Completed
100 enrolled 17 charts
Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage
Phase 2 Recruiting
50 enrolled
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
Phase 2 Completed
17 enrolled 5 charts
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
Phase 2 Completed
23 enrolled 14 charts
AflacLL1901 (CHOA-AML)
Phase 2 Terminated
8 enrolled 12 charts
ALL2518
Phase 2 Terminated
7 enrolled
VIDL+ASCT
Phase 2 Unknown
27 enrolled
LAL0904
Phase 2 Completed
470 enrolled 10 charts
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Phase 2 Withdrawn
RADICAL
Phase 2 Unknown
78 enrolled
Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Phase 2 Withdrawn
Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Phase 2 Terminated
12 enrolled 10 charts
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2 Completed
47 enrolled 10 charts
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Phase 2 Completed
163 enrolled
Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL
Phase 2 Unknown
40 enrolled
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 2 Completed
91 enrolled 5 charts
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
Phase 2 Completed
60 enrolled 8 charts
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
Phase 2 Unknown
155 enrolled
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Phase 2 Completed
Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma
Phase 2 Completed
40 enrolled
L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma
Phase 2 Completed
40 enrolled
New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma
Phase 2 Unknown
76 enrolled
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Phase 2 Unknown
120 enrolled